VISTAGEN THERAPEUTICS, INC. Convertible Notes Payable
VISTAGEN THERAPEUTICS, INC. (VTGN) had Convertible Notes Payable of $438.90 thousand as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Balance Sheet › Liabilities › Debt › Long-Term Debt, Unclassified
us-gaap:ConvertibleNotesPayable · last filed 2020-11-12
- 2020-09-30: Convertible Notes Payable $438.90K.
- 2020-06-30: Convertible Notes Payable $428.50K.
- 2020-03-31: Convertible Notes Payable $56.50K.
- 2019-12-31: Convertible Notes Payable $70.50K.
| Period end | Convertible Notes Payable | Convertible Notes Payable as first filed |
|---|---|---|
| 2020-09-30 | $438.90K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $428.50K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $56.50K 10-Q · filed 2020-11-12 | |
| 2019-12-31 | $70.50K 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $159.30K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $246.40K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $57.30K 10-Q · filed 2020-02-13 | |
| 2018-12-31 | $49.10K 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $115.60K 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $181.10K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $53.90K 10-Q · filed 2019-02-12 | |
| 2017-12-31 | $43.70K 10-Q · filed 2018-02-12 | |
| 2017-03-31 | $54.80K 10-Q · filed 2018-02-12 | |
| 2016-12-31 | $35.80K 10-Q · filed 2017-02-13 | |
| 2016-09-30 | $71.10K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $105.90K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $58.80K 10-Q · filed 2017-02-13 | |
| 2013-03-31 | $4.00M 10-K · filed 2013-07-18 | |
| 2012-12-31 | $4.00M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $4.00M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $4.00M 10-Q · filed 2012-08-14 | |
| 2011-12-31 | $0.00 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $3.05M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $2.80M 10-Q · filed 2011-08-22 | |
| 2011-03-31 | $4.81M 10-K · filed 2012-07-02 | $4.81M 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |